Cytoplasmic HuR expression was increased and predictive of poor disease-free survival and overall survival of subjects with surgically-resected CCA who underwent adjuvant gemcitabine-based chemotherapy. This evidence concerns the gene ELAVL1 and cholangiocarcinoma.